Work

Inhibition of PD-L1 by MPDL3280A and clinical activity in pts with metastatic urothelial bladder cancer (UBC).

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.5011

Authors: Thomas Powles, Nicholas J. Vogelzang, Gregg Daniel Fine, Joseph Paul Eder, Fadi S. Braiteh, Yohann Loriot, Cristina Cruz Zambrano, Joaquim Bellmunt, Howard A. Burris, Siew-leng Melinda Teng, Xiaodong Shen, Hartmut Koeppen, Priti S. Hegde, Daniel S. Chen, Daniel Peter Petrylak

Institutions: Queen Mary University of London, Barts Cancer Institute, University of Nevada, Las Vegas, Comprehensive Cancer Centers of Nevada, Genentech, Yale Cancer Center, Institut Gustave Roussy, Vall d'Hebron Hospital Universitari, Harvard University, Dana-Farber Brigham Cancer Center, Sarah Cannon

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2499376400

Cites:

Cited by: 96

Related to: 10